14 |
Preventative Effects of Rosiglitazone on Restenosis after Coronary Stent Implantation |
Donghoon Choi |
Sep. 23. 05 |
13 |
The Promise of the Thiazolidinediones in the Management of Type 2 Diabetes-Associated Cardiovascular Disease |
Stephen Alistair Smith |
Sep. 23. 05 |
12 |
Inflammation: Novel Target for Cardiovascular Risk Reduction |
Andrew Zalewski |
Sep. 23. 05 |
11 |
Mechanisms Linking Angiotensin II & Atherogenesis |
Carlos M. Ferrario |
Sep. 23. 05 |
10 |
Beyond the Statin Therapy: The Importance of HDL Cholesterol |
Ki Hoon Han |
Sep. 23. 05 |
9 |
Early Statin Therapy in Acute Coronary Syndrome |
Cheol Whan Lee |
Sep. 23. 05 |
8 |
The TNT Trial: Is It Time to Shift Our Goals in Clinical Practice |
David Colquhoun |
Sep. 23. 05 |
7 |
Cholesterol Absorption Inhibition: Shaping the Future of Lipid Management |
Ki Hoon Han |
Mar. 11. 05 |
6 |
Making an Impact on Cardiovascular Disease in Your Patients : HPS Indication of Simvastatin Based on Heart Protection Study |
Richard Charles O'brien |
Mar. 11. 05 |
5 |
Early Use of Stain Therapy in Acute Coronary Syndrome; Results in A to Z Trial |
Harvey White |
Mar. 11. 05 |